A new study adds to a growing body of literature suggesting that human insulins may result in similar clinical outcomes as higher cost insulin analogues for many patients with type 2 diabetes, according to a report last week in JAMA. The study looked at an initiative implemented by a Medicare Advantage plan to encourage members with diabetes to switch from insulin analogue to human insulin. The program was associated with a small increase in population-level HbA1C, but no significant change in rates of serious hypoglycemia or hyperglycemia. Human insulin use increased to 70 percent of insulin prescriptions over the three-year initiative, while overall expenditures for insulin decreased by more than 50 percent.

Related News Articles

Headline
Measles cases have been reported by 42 states and jurisdictions this year, with 1,563 total nationwide, according to the latest data released yesterday by the…
Headline
Inova Health System’s Toni Ardabell, chief of clinical enterprise operations, and Sage Bolte, Ph.D., chief philanthropy officer and president of the Inova…
Perspective
Public
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…
Headline
Speakers interested in leading conversations and collaborations at the AHA’s new Healthier Together Conference are advised to submit a content proposal by Sept…
Blog
In this insightful conversation hosted by Nancy Myers of the American Hospital Association, we explore how Owensboro Health (Ky.) and CredibleMind are…
Headline
The AHA will accept applications through Oct. 14 for the 2026 AHA Dick Davidson NOVA Award. This award recognizes hospitals and health systems that demonstrate…